NPAS4 and depressive symptom measurement: Moreover, the majority (66.2%) of the Npas4 shRNA-downregulated genes from our analysis overlapped with upregulated genes in human MDD patients (Figure 5F), suggesting that Npas4 expression could contribute to vulnerability to depression in the human brain.